• Open
  • sdadmin
    September 20, 2018 at 3:59 pm #1478
    1. WHEREAS, food allergies are a growing public health and food safety concern affecting an estimated
    2. 15 million U.S. residents, including 1 in every 13 children1; and
    1. WHEREAS, food-related anaphylaxis is responsible for approximately 30,000 emergency room visits,
    2. 2,000 hospitalizations, and 150 deaths each year in the United States1, and insect venom-related
    3. anaphylaxis is responsible for at least 40 additional deaths each year2; and
    1. WHEREAS, epinephrine is the first-line treatment for anaphylaxis and autoinjectors allow easy and
    2. safe delivery of accurate doses3,4,5; and
    1. WHEREAS, a nationwide study found that the median time to respiratory or cardiac arrest was 30
    2. minutes for food-induced anaphylaxis and 15 minutes for venom-induced anaphylaxis, supporting the
    3. notion that quick intervention is crucial in anaphylaxis5; and
    1. WHEREAS, a majority of anaphylactic deaths, estimated at 87% by one study6, are directly linked to
    2. delayed administration administration3; and
    1. WHEREAS, a number of individuals, including two-thirds of children in one study7, do not have
    2. epinephrine autoinjectors with them at the time of an anaphylactic reaction1,4; and
    1. WHEREAS, as many as 34% of allergic reactions to food and more than 50% of anaphylactic fatalities
    2. occur in restaurants and other locations outside the home1,2; and
    1. WHEREAS, 31 states allow stocking of undesignated epinephrine by public entities (restaurants,
    2. camps, theme parks, sports arenas, etc)8; and
    1. WHEREAS, the American Osteopathic Association (AOA) Epinephrine Products Policy H352-A/18
    2. states that “the AOA will advocate for the availability by legislation of epinephrine products at schools,
    3. restaurants, sporting events and places of business accompanied by appropriate training and funding”9;
    4. and
    1. WHEREAS, members of the Student Osteopathic Medical Association (SOMA) are active within their
    2. respective communities and are in a unique position to advocate directly to community members; now,
    3. therefore, be it

    1. RESOLVED, that the Student Osteopathic Medical Association (SOMA) organizes an educational
    2. campaign to promote an increase in availability and usage of epinephrine autoinjectors in public spaces
    3. and to raise awareness about the benefits of such availability.

    Explanatory Statement
    During the academic year, local SOMA chapters will promote increased awareness and/or availability of epinephrine autoinjectors through a method of the chapter’s choosing. For example, the SOMA chapters in states where legislation allows for the public availability and usage of epinephrine autoinjectors can focus their efforts on educating restaurant owners on benefits of carrying autoinjectors, informing the public on proper usage, or helping fundraise to subsidize costs. For SOMA chapters in states with no such legislation, efforts can be focused on increasing awareness for the need of epinephrine autoinjectors in public spaces.


    1. Waserman, S., Avilla, E., Harada, L., Allen, M., Isaranuwatchai, W., Perdrizet, J., Kastner, M. (2018). To stock or not to stock? Implementation of epinephrine autoinjectors in food establishments. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2018.07.029
    2. Gupta, R.S. (2014). Anaphylaxis in the Young Adult Population. American Journal of Medicine, 127(1), S17-S24.
    3. Sheikh, A. et al. (2012). Adrenaline auto‐injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community. Cochrane Database of Systematic Reviews, (8).
    4. Sicherer, S., Simons, E.R. (2017). Epinephrine for First-aid Management of Anaphylaxis. Pediatrics, 139(3).
    5. Lieberman, P., Nicklas, R., Randolph, C., Oppenheimer, J., Bernstein, D., Bernstein, K., Ellis, A., … Tilles, S.A. (2015). Anaphylaxis- a practice parameter update 2015. Annals of Allergy, Asthma & Immunology, 115(5), 341-384. https://doi.org/10.1016/j.anai.2015.07.019
    6. Bock, S.A., Muñoz-Furlong, A., Sampson, H.A. (2007). Further fatalities caused by anaphylactic reactions to food, 2001-2006. The Journal of Allergy and Clinical Immunology, 119(4), 1016-1018. https://doi.org/10.1016/j.jaci.2006.12.622
    7. Blackman, A., Anvari, S., Anagnostou, A. (2018). Treatment of Anaphylaxis: Are We Doing It Right? Journal of Allergy and Clinical Immunology. 141(2), Supplement AB155. https://doi.org/10.1016/j.jaci.2017.12.496
    8. Food Allergy Research & Education. (2016). Public access to epinephrine. Retrieved from https://www.foodallergy.org/public-access-to-epinephrine
    9. The American Osteopathic Association. (2018). H352-A/18 Epinephrine products- the William G. Anderson, DO initiative- availability of. Retrieved from http://policysearch.wpengine.com/wp-content/uploads/H352-A2018-EPINEPHRINE-PRODUCTS-%E2%80%93-AVAILABILITY-OF.pdf

      Submitted by:
      Jenna Guma, OMS II – Rowan University School of Osteopathic Medicine
      Amanda Rubin, OMS II – Rowan University School of Osteopathic Medicine
      Marian Abdelmalek, OMS II – Rowan University School of Osteopathic Medicine
      Shikha Patel, OMS II – Rowan University School of Osteopathic Medicine
      Nehi Patel, OMS II – Rowan University School of Osteopathic Medicine
      Prutha Shah, OMS II – Rowan University School of Osteopathic Medicine
      Brian Niedzwecki, OMS II – New York Institute of Technology College of Osteopathic Medicine

      Action Taken:


      Effective Time Period: Ongoing

  1. Wessley Square
    October 2, 2018 at 6:55 pm #1963

    This is a topic I personally identify with very strongly and would like to provide additional information in support of this resolution. In addition to the cited AOA policy, the following policies also address epinephrine availability: H350-A/17 and H333-A/17. Furthermore at the HoD this July I met Dr. Markman of Wisconsin who with their state society was supporting “Epi for Dilly” https://epifordilly.wordpress.com/ and advocating for a change in state legislation to allow for trained individuals to dispense epinephrine outside of the previously more narrowed restrictions (for instance school nurses previously only being allowed to deliver epinephrine at school and not for instance the shopping market). They also held workshops to train people on epinephrine delivery. I think these would be fantastic SOMA projects and I have been in touch with Dr. Markman so that once supported by proper SOMA policy we can pull the trigger on this potentially lifesaving campaign and push for better epinephrine legislation and availability everywhere.